MeVis Medical Solutions AG (FRA:M3V)

Germany flag Germany · Delayed Price · Currency is EUR
25.20
0.00 (0.00%)
At close: May 30, 2025, 10:00 PM CET
-4.55%
Market Cap 45.86M
Revenue (ttm) 16.64M
Net Income (ttm) 4.30M
Shares Out n/a
EPS (ttm) 2.36
PE Ratio 10.66
Forward PE n/a
Dividend 0.95 (3.77%)
Ex-Dividend Date Mar 26, 2025
Volume 20
Average Volume 139
Open 25.20
Previous Close 25.20
Day's Range 25.20 - 25.20
52-Week Range 22.80 - 26.80
Beta n/a
RSI 33.44
Earnings Date May 27, 2025

About FRA:M3V

MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resona... [Read more]

Industry Prepackaged Software
Founded 1997
Employees 100
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol M3V
Full Company Profile

Financial Performance

In 2024, FRA:M3V's revenue was 16.97 million, a decrease of -2.14% compared to the previous year's 17.34 million. Earnings were 4.56 million, a decrease of -7.29%.

Financial Statements

News

MeVis Unveils H1 2024/25 Results Amid EUR/USD Trends

MeVis Medical Solutions AG navigates a challenging fiscal landscape, reporting a slight dip in revenue and EBIT for the first half of 2024/2025, yet remains optimistic about future growth. Jetzt den v...

10 days ago - Wallstreet:Online

EQS-News: MeVis publishes figures for the first half of fiscal year 2024/2025

EQS-News: MeVis Medical Solutions AG / Key word(s): Half Year Report/Half Year Results MeVis publishes figures for the first half of fiscal year 2024/2025 27.05.2025 / 15:45 CET/CEST The issuer is sol...

10 days ago - Wallstreet:Online